Serina Therapeutics (SER) Non Operating Income (2018 - 2026)

Serina Therapeutics has disclosed Non Operating Income across 9 years of filings, most recently posting $428000.0 for Q2 2026.

• In Q2 2026, Non Operating Income rose 147.71% year-over-year to $428000.0; the TTM figure through Jun 2026 stood at $4.2 million (down 56.21% YoY), while the FY2025 annual figure was $4.8 million, down 17.39% from the prior year.
• Non Operating Income came in at $428000.0 for Q2 2026 at Serina Therapeutics, down from $2.9 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $9.0 million in Q2 2024 to a low of -$12.7 million in Q1 2024.
• Average Non Operating Income over 5 years is $937941.2, with a median of $1.0 million recorded in 2025.
• Year-over-year, Non Operating Income jumped 500.0% in 2023 and slumped 584.5% in 2024.
• Over 5 years, Non Operating Income stood at -$979000.0 in 2022, then jumped by 182.74% to $810000.0 in 2023, then soared by 245.31% to $2.8 million in 2024, then climbed by 3.29% to $2.9 million in 2025, then slumped by 85.19% to $428000.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were $428000.0 in Q2 2026, $2.9 million in Q4 2025, and $1.8 million in Q3 2025.